News & Updates
Showing Infectious Diseases articles
Showing
Show Multimedia Only

Real-world HK study: Nirmatrelvir/ritonavir reduces hospitalizations in COVID-19 patients
22 Sep 2022
byChristina Lau
The oral antiviral nirmatrelvir/ritonavir, but not molnupiravir, reduces the risk of hospitalization among community COVID-19 patients in Hong Kong, a real-world territory-wide retrospective cohort study has shown.
22 Sep 2022

Vebicorvir plus Nrtl safe, well tolerated in patients with chronic HBV infection
16 Sep 2022
byStephen Padilla
Treatment with vebicorvir (VBR) plus nucleos(t)ide reverse transcriptase inhibitors (NrtIs) among virologically suppressed patients with chronic hepatitis B virus (HBV) is well tolerated and has a favourable safety profile, according to a 24-week study.
16 Sep 2022






